STEMCELLS
Research STEMCELLS (SCS.WA) on Bullrun: market cap PLN 19.43M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSCS.WA
- ExchangeXNCO
- CountryPoland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyPLN
- Market capPLN 19.43M
- Financial periodQ2 2026
- RevenuePLN 18.29K
- Net income-PLN 154.31K
- Free cash flow-PLN 47.81K
- Gross margin91.2%
Valuation Snapshot
latest market cap is PLN 19.43M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-11 | PLN 19.43M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 PLN.
About STEMCELLS
Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and usage of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name. The company was founded in 2009 and is based in Wroclaw, Poland. Stem Cells Spin S.A. operates as a subsidiary of Medcervin Sp. Z O.O.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is STEMCELLS's market cap?
STEMCELLS's market capitalization is PLN 19.43M.
What does STEMCELLS do?
Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and usage of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name. The company was founded in 2009 and is based in Wroclaw, Poland. Stem Cells Spin S.A. operates as a subsidiary of Medcervin Sp. Z O.O.